10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2016 | |||
Consolidated Statement of Earnings | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net Sales | $ 20,853 | 20,405 | 20,247 |
| Cost of products sold, excluding amortization of intangible assets | 9,024 | 8,747 | 9,218 |
| Amortization of intangible assets | 550 | 601 | 555 |
| Research and development | 1,422 | 1,405 | 1,345 |
| Selling, general and administrative | 6,672 | 6,785 | 6,530 |
| Total Operating Cost and Expenses | 17,668 | 17,538 | 17,648 |
| Operating Earnings | 3,185 | 2,867 | 2,599 |
| Interest expense | 431 | 163 | 150 |
| Interest income | (99) | (105) | (77) |
| Net loss on extinguishment of debt | 18 | ||
| Net foreign exchange (gain) loss | 495 | (93) | (24) |
| Other (income) expense, net | 945 | (281) | 14 |
| Earnings from Continuing Operations Before Taxes | 1,413 | 3,183 | 2,518 |
| Taxes on Earnings from Continuing Operations | 350 | 577 | 797 |
| Earnings from Continuing Operations | 1,063 | 2,606 | 1,721 |
| Earnings from Discontinued Operations, net of taxes | 321 | 65 | 563 |
| Gain on sale of Discontinued Operations, net of taxes | 16 | 1,752 | |
| Net Earnings from Discontinued Operations, net of taxes | 337 | 1,817 | 563 |
| Net Earnings | 1,400 | 4,423 | 2,284 |
| Basic Earnings Per Common Share -- | |||
| Continuing Operations (in dollars per share) | 0.71 | 1.73 | 1.13 |
| Discontinued Operations (in dollars per share) | 0.23 | 1.21 | 0.37 |
| Net Earnings (in dollars per share) | 0.94 | 2.94 | 1.50 |
| Diluted Earnings Per Common Share -- | |||
| Continuing Operations (in dollars per share) | 0.71 | 1.72 | 1.12 |
| Discontinued Operations (in dollars per share) | 0.23 | 1.20 | 0.37 |
| Net Earnings (in dollars per share) | 0.94 | 2.92 | 1.49 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1,477 | 1,496 | 1,516 |
| Dilutive Common Stock Options (in shares) | 6 | 10 | 11 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) | 1,483 | 1,506 | 1,527 |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 5 | 1 | 1 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2016 | |||
Consolidated Statement of Comprehensive Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Net Earnings (Loss) | $ 1,400 | 4,423 | 2,284 |
| Foreign currency translation (loss) adjustments | (130) | (2,013) | (2,206) |
| Net actuarial gains (losses) and prior service cost and credits and amortization of net actuarial losses and prior service cost and credits, net of taxes of $(125) in 2016, $101 in 2015 and $(459) in 2014 | (326) | 252 | (917) |
| Unrealized gains (losses) on marketable equity securities, net of taxes of $(28) in 2016, $104 in 2015 and $(7) in 2014 | (134) | 64 | (12) |
| Net (losses) gains on derivative instruments designated as cash flow hedges, net of taxes of $(4) in 2016, $(9) in 2015 and $24 in 2014 | (15) | (35) | 94 |
| Other Comprehensive (Loss) Income | (605) | (1,732) | (3,041) |
| Comprehensive Income (Loss) | 795 | 2,691 | (757) |
| Supplemental Accumulated Other Comprehensive Income Information, net of tax as of December 31: | |||
| Cumulative foreign currency translation (loss) adjustments | (4,959) | (4,829) | (2,924) |
| Net actuarial (losses) and prior service (cost) and credits | (2,284) | (1,958) | (2,229) |
| Cumulative unrealized (losses) gains on marketable equity securities | (69) | 65 | 1 |
| Cumulative gains on derivative instruments designated as cash flow hedges | 49 | 64 | 99 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ABBOTT LABORATORIES | |||
Ticker: ABT Fiscal Year: 2016 | |||
Consolidated Statement of Cash Flows | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Cash Flow From (Used in) Operating Activities: | |||
| Net earnings | $ 1,400 | 4,423 | 2,284 |
| Adjustments to reconcile earnings to net cash from operating activities - | |||
| Depreciation | 803 | 871 | 918 |
| Amortization of intangible assets | 550 | 601 | 630 |
| Share-based compensation | 310 | 292 | 246 |
| Impact of currency devaluation | 480 | ||
| Investing and financing (gains) losses, net | 86 | (18) | 69 |
| Amortization of bridge financing fees | 165 | ||
| Net loss on extinguishment of debt | 18 | ||
| Gain on sale of discontinued operations | (25) | (2,840) | |
| Mylan N.V. equity investment adjustment | 947 | ||
| Gain on sale of Mylan N.V. shares | (207) | ||
| Trade receivables | (177) | (171) | (195) |
| Inventories | (98) | (257) | (297) |
| Prepaid expenses and other assets | 113 | 57 | 30 |
| Trade accounts payable and other liabilities | (652) | (742) | (225) |
| Income taxes | (699) | 957 | 197 |
| Net Cash From Operating Activities | 3,203 | 2,966 | 3,675 |
| Cash Flow From (Used in) Investing Activities: | |||
| Acquisitions of property and equipment | (1,121) | (1,110) | (1,077) |
| Acquisitions of businesses and technologies, net of cash acquired | (80) | (235) | (3,317) |
| Proceeds from business dispositions | 25 | 230 | 5 |
| Proceeds from the sale of Mylan N.V. shares | 2,290 | ||
| Purchases of investment securities | (2,823) | (4,933) | (1,507) |
| Proceeds from sales of investment securities | 3,709 | 4,112 | 5,624 |
| Other | 42 | 52 | 70 |
| Net Cash From (Used in) Investing Activities | (248) | 406 | (202) |
| Cash Flow From (Used in) Financing Activities: | |||
| Proceeds from issuance of (repayments of) short-term debt and other | (1,767) | (1,281) | 1,343 |
| Proceeds from issuance of long-term debt and debt with maturities over 3 months | 14,934 | 2,485 | |
| Repayments of long-term debt and debt with maturities over 3 months | (12) | (57) | (577) |
| Payment of bridge financing fees | (170) | ||
| Acquisition and contingent consideration payments related to business acquisitions | (25) | (17) | (400) |
| Purchases of common shares | (522) | (2,237) | (2,195) |
| Proceeds from stock options exercised, including income tax benefit | 248 | 314 | 429 |
| Dividends paid | (1,539) | (1,443) | (1,342) |
| Net Cash From (Used in) Financing Activities | 11,147 | (2,236) | (2,742) |
| Effect of exchange rate changes on cash and cash equivalents | (483) | (198) | (143) |
| Net (Decrease) Increase in Cash and Cash Equivalents | 13,619 | 938 | 588 |
| Cash and Cash Equivalents, Beginning of Year | 5,001 | 4,063 | |
| Cash and Cash Equivalents, End of Year | 18,620 | 5,001 | 4,063 |
| Supplemental Cash Flow Information: | |||
| Income taxes paid | 620 | 631 | 448 |
| Interest paid | 181 | 166 | 146 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2016 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2016 10-K (Filed: Feb 17, 2017) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2016 | Dec 31, 2015 | |
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 18,620 | 5,001 |
| Investments, primarily bank time deposits and U.S. treasury bills | 155 | 1,124 |
| Trade receivables, less allowances of - 2016: $250; 2015: $337 | 3,248 | 3,418 |
| Inventories: | ||
| Finished products | 1,624 | 1,744 |
| Work in process | 294 | 316 |
| Materials | 516 | 539 |
| Total inventories | 2,434 | 2,599 |
| Other prepaid expenses and receivables | 1,806 | 1,908 |
| Current assets held for disposition | 513 | 105 |
| Total Current Assets | 26,776 | 14,155 |
| Long-term Investments | 2,947 | 4,041 |
| Property and Equipment, at Cost: | ||
| Land | 408 | 432 |
| Buildings | 2,602 | 2,769 |
| Equipment | 8,394 | 8,254 |
| Construction in progress | 962 | 928 |
| Property and Equipment, at cost | 12,366 | 12,383 |
| Less: accumulated depreciation and amortization | 6,661 | 6,653 |
| Net Property and Equipment | 5,705 | 5,730 |
| Intangible Assets, net of amortization | 4,539 | 5,562 |
| Goodwill | 7,683 | 9,638 |
| Deferred Income Taxes and Other Assets | 2,263 | 2,119 |
| Non-current Assets Held for Disposition | 2,753 | 2 |
| Total Assets | 52,666 | 41,247 |
| Liabilities and Shareholders' Investment | ||
| Current Liabilities: | ||
| Short-term borrowings | 1,322 | 3,127 |
| Trade accounts payable | 1,178 | 1,081 |
| Salaries, wages and commissions | 752 | 746 |
| Other accrued liabilities | 2,581 | 3,043 |
| Dividends payable | 391 | 383 |
| Income taxes payable | 188 | 430 |
| Current portion of long-term debt | 3 | 3 |
| Current liabilities held for disposition | 245 | 373 |
| Total Current Liabilities | 6,660 | 9,186 |
| Long-term Debt | 20,681 | 5,871 |
| Post-employment Obligations and other long-term liabilities | 4,549 | 4,864 |
| Non-current liabilities held for disposition | 59 | |
| Commitments and Contingencies | ||
| Shareholders' Investment: | ||
| Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
| Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2016: 1,707,475,455; 2015: 1,702,017,390 | 13,027 | 12,734 |
| Common shares held in treasury, at cost - Shares: 2016: 234,606,250; 2015: 229,352,338 | (10,791) | (10,622) |
| Earnings employed in the business | 25,565 | 25,757 |
| Accumulated other comprehensive income (loss) | (7,263) | (6,658) |
| Total Abbott Shareholders' Investment | 20,538 | 21,211 |
| Noncontrolling Interests in Subsidiaries | 179 | 115 |
| Total Shareholders' Investment | 20,717 | 21,326 |
| Total Liabilities and Shareholders' Investment | 52,666 | 41,247 |
| External Links | |
| ABBOTT LABORATORIES (ABT) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |